Loading…
Based on limited metadata without access to the full letter text, the FDA issued a warning to 4nrx.md, a company involved with drug products, on May 13, 2020. While the specific violations are not detailed in the available metadata, the warning falls under FDA's drug regulatory authority. Without the subject line or complete letter contents, the precise nature of the compliance issues cannot be determined from this information alone.